Porton Biopharma Ltd.   Report issue

For profit Phase 1
Founded: Porton Down United Kingdom (2015)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2019
NCT04148118
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Porton Biopharma Ltd.

Active Ingredients

Drugs in Phase 1 Trials (2)

anthrax vaccine, adsorbed (Biothrax) (1 trial)

bw-1010 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anthrax (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2